Artesunate/Pyronaridine Phosphate

青蒿琥酯/磷酸咯萘啶

Report date: 2022/03/22 11:18:41

Base Information

Drug NameArtesunate/Pyronaridine Phosphate
Drug Alias NamePyronaridine Phosphate and Artesunate青蒿琥酯磷酸咯萘啶Artesunate and Pyronaridine Phosphate磷酸咯萘啶/青蒿琥酯Pyronaridine Phosphate and Artesunic acid +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSarcoplasmic/endoplasmic reticulum calcium ATPase 2 inhibitorsSarcoplasmic/endoplasmic reticulum calcium ATPase 1 inhibitors
TargetsSarcoplasmic/endoplasmic reticulum calcium ATPase 2Sarcoplasmic/endoplasmic reticulum calcium ATPase 1
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Malaria, FalciparumMalaria
Global Approved IndicationsMalaria
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date2012/01/01
Country/TerritoryPolandUgandaSenegal +[18] 
CombinationsYes ArtesunatePyronaridine Phosphate
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesShin Poong Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesInstitute Of Tropical Medicine, University Of TuebingenUniversity Of KinshasaLiverpool School Of Tropical Medicine +[4] 
Inactive CompaniesUniversity Of OxfordKit Hotel Bv
Active IndicationsCoronavirus Disease 2019 (COVID-19)Malaria, FalciparumMalaria
Inactive IndicationsN/A

Other Information

ATC CodeP01B
Related LinksN/A